Norman Relkin, MD, PhD, is a 23 year faculty member of Cornell’s Medical College (New York, NY), as well as a clinical neurologist and neuroscientist. Dr. Relkin is an internationally recognized expert on Alzheimer’s disease and related disorders. He pioneered the study of naturally occurring human antibodies for the treatment of Alzheimer’s and has over 20 years of experience in design of clinical trials.
Dr. Relkin is a reviewer for the National Institute of Health (NIH) and sits on the editorial board of 3 major scientific journals. Over the last 25 years, Dr. Relkin has authored numerous publications on neurodegenerative and traumatic disorders of the brain.